Home / Resources and Insights / Case Study: Accelerate Commercial Manufacturing of an Oligon...
Case Study: Accelerate Commercial Manufacturing of an Oligonucleotide Adjuvant with WuXi Speed
Less than 1 min read time
Discover how WuXi STA helped a biotech company accelerate commercial manufacturing of an oligonucleotide adjuvant, meeting strict quality standards and...
Discover how WuXi STA helped a biotech company accelerate commercial manufacturing of an oligonucleotide adjuvant, meeting strict quality standards and tight timelines with their integrated CRDMO capabilities. This case study demonstrates WuXi Speed in delivering commercial-scale single-strand DNA manufacturing.
Related Reading
Video
Case Study: PDC Drug R&D and Manufacturing in 9 Months
Video
The Latest Progress Update on Our Middletown, DE, facility (2025)
Video
Case Study: Enable an Innovative GLP-1 GCG Dual Peptide Program IND filing in Just 10 Months
How WuXi TIDES Enabled an Innovative GLP-1 GCG Dual Peptide Program IND filing in Just 10 Months As GLP-1 receptor...